2012 Economic Outlook -- Report Highlights Alexion Pharmaceuticals, Inc. and ... MarketWatch (press release) ... development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeutic areas of hematology, nephrology (including transplant rejection), neurology, ... |